At present, plenty of drugs targeting NLRP3 inflammasome have been proved to have a good effect on metabolic diseases, such as Anakinra (IL-1 receptor antagonist) and Atorvastatin (inhibits TLR4/MyD88 ...
Host cells activate cell death pathways in response to bacterial manipulation of innate immune signalling, but the molecular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback